BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23162127)

  • 21. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report.
    Acharya IL; Lowe CU; Thapa R; Gurubacharya VL; Shrestha MB; Cadoz M; Schulz D; Armand J; Bryla DA; Trollfors B
    N Engl J Med; 1987 Oct; 317(18):1101-4. PubMed ID: 3657877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experience with Salmonella typhi Vi capsular polysaccharide vaccine.
    Hessel L; Debois H; Fletcher M; Dumas R
    Eur J Clin Microbiol Infect Dis; 1999 Sep; 18(9):609-20. PubMed ID: 10534182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi.
    Kothari N; Kothari S; Choi YJ; Dey A; Briles DE; Rhee DK; Carbis R
    Vaccine; 2015 Feb; 33(6):783-8. PubMed ID: 25545593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological evaluation of Vi capsular polysaccharide of Salmonella enterica subsp. Typhi vaccine by serum bactericidal assay.
    Ahmadi H; Tabaraie B; Maleknia S; Shapouri R; Nejati M; Pour Mirza Gholi F; Hedayati M; Sadati M; Zahednia S; Sharifat Salmani A
    J Med Microbiol; 2013 Feb; 62(Pt 2):283-286. PubMed ID: 23105026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isotypes of human vaccinal antibodies to the Vi capsular polysaccharide of Salmonella typhi.
    Brugier JC; Barra A; Schulz D; Preud'homme JL
    Int J Clin Lab Res; 1993; 23(1):38-41. PubMed ID: 8477090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Terminal Deoxynucleotidyl Transferase Is Not Required for Antibody Response to Polysaccharide Vaccines against Streptococcus pneumoniae and Salmonella enterica Serovar Typhi.
    Belde V; Cravens MP; Gulandijany D; Walker JA; Palomo-Caturla I; Alugupalli AS; Sandilya VK; Mahmoud T; Bäumler AJ; Kearney JF; Alugupalli KR
    Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29967094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A recombinant protein of Salmonella Typhi induces humoral and cell-mediated immune responses including memory responses.
    Das S; Chowdhury R; Ghosh S; Das S
    Vaccine; 2017 Aug; 35(35 Pt B):4523-4531. PubMed ID: 28739115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistence of antibody titres three years after vaccination with Vi polysaccharide vaccine against typhoid fever.
    Tacket CO; Levine MM; Robbins JB
    Vaccine; 1988 Aug; 6(4):307-8. PubMed ID: 3188615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vi capsular polysaccharide: Synthesis, virulence, and application.
    Hu X; Chen Z; Xiong K; Wang J; Rao X; Cong Y
    Crit Rev Microbiol; 2017 Aug; 43(4):440-452. PubMed ID: 27869515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of purified Vi polysaccharide typhoid vaccine.
    Park JH; Hong JJ; Choi ES; Lee JW; Park JH
    J Vet Sci; 2002 Jun; 3(2):67-70. PubMed ID: 12441674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of Vi capsular polysaccharide synthesis in Salmonella enterica serotype Typhi.
    Santander J; Roland KL; Curtiss R
    J Infect Dev Ctries; 2008 Dec; 2(6):412-20. PubMed ID: 19745516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salmonella Typhi outer membrane protein STIV is a potential candidate for vaccine development against typhoid and paratyphoid fever.
    Das S; Chowdhury R; Pal A; Okamoto K; Das S
    Immunobiology; 2019 May; 224(3):371-382. PubMed ID: 30952553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal
    Schager AE; Dominguez-Medina CC; Necchi F; Micoli F; Goh YS; Goodall M; Flores-Langarica A; Bobat S; Cook CNL; Arcuri M; Marini A; King LDW; Morris FC; Anderson G; Toellner KM; Henderson IR; López-Macías C; MacLennan CA; Cunningham AF
    mBio; 2018 Mar; 9(2):. PubMed ID: 29511082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serological response following re-vaccination with Salmonella typhi Vi-capsular polysaccharide vaccines in healthy adult travellers.
    Roggelin L; Vinnemeier CD; Fischer-Herr J; Johnson-Weaver BT; Rolling T; Burchard GD; Staats HF; Cramer JP
    Vaccine; 2015 Aug; 33(33):4141-5. PubMed ID: 26144902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of monoclonal antibodies to Vi polysaccharide antigen of Salmonella typhi.
    Pongsunk S; Sarasombath S; Ekpo P; Tangtherawattana P; Levine MM
    Asian Pac J Allergy Immunol; 1993 Jun; 11(1):53-6. PubMed ID: 8216560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An evaluation of purified Salmonella Typhi protein antigens for the serological diagnosis of acute typhoid fever.
    Tran Vu Thieu N; Trinh Van T; Tran Tuan A; Klemm EJ; Nguyen Ngoc Minh C; Voong Vinh P; Pham Thanh D; Ho Ngoc Dan T; Pham Duc T; Langat P; Martin LB; Galan J; Liang L; Felgner PL; Davies DH; de Jong HK; Maude RR; Fukushima M; Wijedoru L; Ghose A; Samad R; Dondorp AM; Faiz A; Darton TC; Pollard AJ; Thwaites GE; Dougan G; Parry CM; Baker S
    J Infect; 2017 Aug; 75(2):104-114. PubMed ID: 28551371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired antibody response after immunization of HIV-infected individuals with the polysaccharide vaccine against Salmonella typhi (Typhim-Vi).
    Kroon FP; van Dissel JT; Ravensbergen E; Nibbering PH; van Furth R
    Vaccine; 1999 Aug; 17(23-24):2941-5. PubMed ID: 10462227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of two Salmonella typhimurium hybrids as challenge organisms in a system for the assay of typhoid vaccines.
    Johnson EM; Diena BB; Lior H; Ryan A; Krol P; Baron LS
    Infect Immun; 1982 Oct; 38(1):201-5. PubMed ID: 6754614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcutaneous Vaccination with Conjugate Typhoid Vaccine Vi-DT Induces Systemic, Mucosal, and Memory Anti-Polysaccharide Responses.
    Bhuiyan MS; Kalsy A; Arifuzzaman M; Charles RC; Harris JB; Calderwood SB; Qadri F; Ryan ET
    Am J Trop Med Hyg; 2020 Sep; 103(3):1032-1038. PubMed ID: 32720632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children.
    Lin FY; Ho VA; Khiem HB; Trach DD; Bay PV; Thanh TC; Kossaczka Z; Bryla DA; Shiloach J; Robbins JB; Schneerson R; Szu SC
    N Engl J Med; 2001 Apr; 344(17):1263-9. PubMed ID: 11320385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.